EP Patent

EP1488807A4 — MEDICAMENTS FOR TREATING SEXUAL HORMONE DEPENDENT DISEASE

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2009-07-08 · 17y expired

What this patent protects

It is intended to provide drugs with the combined use of an LHRH receptor agonist or antagonist with an androgen receptor agonist which are useful as preventives or remedies for hormone-dependent diseases, etc.

USPTO Abstract

It is intended to provide drugs with the combined use of an LHRH receptor agonist or antagonist with an androgen receptor agonist which are useful as preventives or remedies for hormone-dependent diseases, etc.

Drugs covered by this patent

Patent Metadata

Patent number: EP1488807A4
Jurisdiction: EP
Classification: —
Expires: 2009-07-08
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.